We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genetic Decoding Improved for Neurodevelopmental Disorders

By LabMedica International staff writers
Posted on 23 Oct 2017
DLG2 gene study as a case in point that will help facilitate future diagnosis of children with neurodevelopmental disorders (NDDs), such as intellectual disability, autism, or early-onset symptoms of psychiatric diseases such as schizophrenia.

NDDs are a group of often severe pediatric conditions. More...
The recent development of higher resolution genetic diagnostic tools has underlined the prevalence of genetic anomalies (e.g. gene copy-number variations) in children with NDDs.

In the study, two patients at Queen Fabiola Children's University Hospital (HUDERF; Brussels, Belgium) with NDDs (here cognitive and behavioral symptoms) showed partial loss, by deletion, of the DLG2 gene, which plays an important role in the development, plasticity, and stability of synapses.

A research team led by Dr. Guillaume Smits, Dr. Nicolas Deconinck, and Dr. Catheline Vilain of HUDERF and Prof. Gianluca Bontempi of ULB collaborated through the Interuniversity Institute of Bioinformatics in Brussels (IB), a joint research institute at Free University of Brussels (ULB; Brussels, Belgium) and Vrije Universiteit Brussel (VUB). Together, they worked at integrating large genomic, epigenomic, transcriptomic, and clinical datasets. The computational experiments, performed by Claudio Reggiani, a PhD student, pinpointed 2 novel DLG2 promoters and coding exons conserved in human and mouse and present in the fetal brain. The deletion of these new regions was found statistically associated with developmental delay and intellectual disability in 2 independent patient cohorts, supporting the pathogenic role of these new elements into the neurodevelopmental symptoms of both HUDERF patients. The findings are presented in a paper and summarized in a video.

From a medical perspective, the findings will help medical doctors in improving future diagnosing of children with NDDs. From a scientific point of view, this work shows how the in silico integration of multiple large datasets can bring knowledge about the genome. It also provides elegant progress into the molecular cause of NDDs and improves fundamental knowledge about the DLG2 gene.

The study, by Reggiani C et al, was published July 19, 2017, in the journal Genome Medicine.

Related Links:
Queen Fabiola Children's University Hospital
Free University of Brussels
Vrije Universiteit Brussel

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.